These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 17407044)
1. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044 [TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. Casoli C; Pilotti E; Bertazzoni U AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939 [TBL] [Abstract][Full Text] [Related]
3. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients. Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825 [TBL] [Abstract][Full Text] [Related]
4. Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients. Bhatt NB; Gudo ES; Semá C; Bila D; Di Mattei P; Augusto O; Garsia R; Jani IV Int J STD AIDS; 2009 Dec; 20(12):863-8. PubMed ID: 19948902 [TBL] [Abstract][Full Text] [Related]
5. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. Lee TH; Chafets DM; Busch MP; Murphy EL J Clin Virol; 2004 Dec; 31(4):275-82. PubMed ID: 15494269 [TBL] [Abstract][Full Text] [Related]
6. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. Brites C; Sampalo J; Oliveira A AIDS Rev; 2009; 11(1):8-16. PubMed ID: 19290030 [TBL] [Abstract][Full Text] [Related]
7. Low DNA HTLV-2 proviral load among women in São Paulo City. Montanheiro P; Olah I; Fukumori LM; Smid J; Oliveira AC; Kanzaki LI; Fonseca LA; Duarte AJ; Casseb J Virus Res; 2008 Jul; 135(1):22-5. PubMed ID: 18343520 [TBL] [Abstract][Full Text] [Related]
8. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II. Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients. Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081 [TBL] [Abstract][Full Text] [Related]
10. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. Murphy EL; Lee TH; Chafets D; Nass CC; Wang B; Loughlin K; Smith D; J Infect Dis; 2004 Aug; 190(3):504-10. PubMed ID: 15243924 [TBL] [Abstract][Full Text] [Related]
11. Neurological aspects of HIV/human T lymphotropic virus coinfection. Tulius Silva M; de Melo Espíndola O; Bezerra Leite AC; Araújo A AIDS Rev; 2009; 11(2):71-8. PubMed ID: 19529747 [TBL] [Abstract][Full Text] [Related]
12. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005. Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S; Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319 [TBL] [Abstract][Full Text] [Related]
13. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. Kwaan N; Lee TH; Chafets DM; Nass C; Newman B; Smith J; Garratty G; Murphy EL; J Infect Dis; 2006 Dec; 194(11):1557-64. PubMed ID: 17083040 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Beilke MA; Theall KP; O'Brien M; Clayton JL; Benjamin SM; Winsor EL; Kissinger PJ Clin Infect Dis; 2004 Jul; 39(2):256-63. PubMed ID: 15307036 [TBL] [Abstract][Full Text] [Related]
15. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients. Ramirez E; Cartier L; Torres M; Barria M J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906 [TBL] [Abstract][Full Text] [Related]
16. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I. Moriuchi H; Moriuchi M Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373 [TBL] [Abstract][Full Text] [Related]
17. Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1. Silva MT; Neves ES; Grinsztejn B; de Melo Espíndola O; Schor D; Araújo A AIDS; 2012 Feb; 26(4):521-3. PubMed ID: 21881482 [TBL] [Abstract][Full Text] [Related]
18. Human T-lymphotropic virus/HIV co-infection: a clinical review. Dhasmana D; Taylor GP Curr Opin Infect Dis; 2014 Feb; 27(1):16-28. PubMed ID: 24305042 [TBL] [Abstract][Full Text] [Related]
19. Human T lymphotropic virus 1 and hepatitis C virus as risk factors for inflammatory dermatoses in HIV-positive patients. Bonamigo RR; Borges K; Rietjens J; Arenzon S; Blanco LF; Loureiro R Int J Dermatol; 2004 Aug; 43(8):568-70. PubMed ID: 15304178 [TBL] [Abstract][Full Text] [Related]